Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-06 08:00 am Unchanged | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 14,040,000 8.54% | 0 (Unchanged) | View |
| 2023-01-19 4:00 pm Sale | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 0 0% | -25,210,000 (Position Closed) | View |
| 2023-01-10 8:04 pm Purchase | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 25,210,000 6.24% | 1,210,000 (+5.04%) | View |
| 2022-10-11 4:30 pm Purchase | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 24,000,000 5.95% | 24,000,000 (New Position) | View |
| 2022-10-07 5:24 pm Unchanged | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 14,040,000 8.55% | 0 (Unchanged) | View |
| 2022-07-06 5:15 pm Unchanged | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 14,040,000 8.55% | 0 (Unchanged) | View |
| 2022-06-15 9:13 pm Sale | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 0 0% | -24,000,000 (Position Closed) | View |
| 2022-06-03 09:17 am Unchanged | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 24,000,000 6.05% | 0 (Unchanged) | View |
| 2022-01-24 5:00 pm Purchase | 13D | AMARIN CORP PLC SPONSORED ADR AMRN | Sarissa Capital Management LP | 24,000,000 6.06% | 24,000,000 (New Position) | View |
| 2022-01-10 4:31 pm Purchase | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 14,040,000 8.68% | 827,000 (+6.26%) | View |
| 2021-11-19 4:15 pm Purchase | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 13,213,000 8.17% | 68,000 (+0.52%) | View |
| 2021-09-10 5:19 pm Purchase | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 13,145,000 8.15% | 1,900,000 (+16.90%) | View |
| 2021-05-27 5:04 pm Purchase | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 11,245,000 7.01% | 1,775,000 (+18.74%) | View |
| 2021-05-25 5:05 pm Unchanged | 13D | INNOVIVA INC INVA | Sarissa Capital Management LP | 6,414,000 9.24% | 0 (Unchanged) | View |
| 2021-05-10 5:03 pm Purchase | 13D | ALKERMES PLC ALKS | Sarissa Capital Management LP | 9,470,000 5.9% | 9,470,000 (New Position) | View |
| 2021-03-01 5:14 pm Purchase | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 14,927,844 9.3% | 14,927,844 (New Position) | View |
| 2021-02-12 5:01 pm Sale | 13D | ITERUM THERAPEUTICS LTD ITRM | Sarissa Capital Management LP | 0 0% | -19,292,768 (Position Closed) | View |
| 2021-01-25 4:43 pm Purchase | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Sarissa Capital Management LP | 8,844,000 5% | 8,844,000 (New Position) | View |
| 2021-01-25 4:42 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | Sarissa Capital Management LP | 3,770,000 5.5% | 20,000 (+0.53%) | View |
| 2020-12-14 08:03 am Purchase | 13D | INNOVIVA INC INVA | Sarissa Capital Management LP | 6,414,000 6.33% | 617,900 (+10.66%) | View |